臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"lin c l"的相關文件

回到依作者瀏覽
依題名排序	依日期排序

顯示項目 111-135 / 848 (共34頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
臺大學術典藏	2022-01-24T09:32:10Z	Long-term tracking of hepatitis B viral load and the relationship with risk for hepatocellular carcinoma in men	Wu C.-F.; Yu M.-W.; Lin C.-L.; CHUN-JEN LIU; Shih W.-L.; Tsai K.-S.; Chen C.-J.
臺大學術典藏	2022-01-24T09:32:06Z	Body-mass index and progression of hepatitis B: A population-based cohort study in men	Yu M.-W.; Shih W.-L.; Lin C.-L.; CHUN-JEN LIU; Jian J.-W.; Tsai K.-S.; Chen C.-J.
臺大學術典藏	2022-01-24T09:32:02Z	Evidence for association with hepatocellular carcinoma at the PAPSS1 locus on chromosome 4q25 in a family-based study	Shih W.-L.; Yu M.-W.; Chen P.-J.; Wu T.-W.; Lin C.-L.; CHUN-JEN LIU; Lin S.-M.; Tai D.-I.; Lee S.-D.; Liaw Y.-F.
臺大學術典藏	2022-01-24T09:31:57Z	Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-α-2a therapy	Tseng T.-C.; Yu M.-L.; CHUN-JEN LIU; Lin C.-L.; Huang Y.-W.; Hsu C.-S.; Liu C.-H.; Kuo S.F.-T.; Pan C.J.-H.; Yang S.-S.; Su C.-W.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2022-01-24T09:31:56Z	Hepatitis B viraemia: Its heritability and association with common genetic variation in the interferon γ signalling pathway	Huang H.-H.; Shih W.-L.; Li Y.-H.; Wu C.-F.; Chen P.-J.; Lin C.-L.; CHUN-JEN LIU; Liaw Y.-F.; Lin S.-M.; Lee S.-D.; Yu M.-W.
臺大學術典藏	2022-01-24T09:31:54Z	Insulin, glucose and hepatocellular carcinoma risk in male hepatitis B carriers: Results from 17-year follow-up of a population-based cohort	Chao L.-T.; Wu C.-F.; Sung F.-Y.; Lin C.-L.; CHUN-JEN LIU; Huang C.-J.; Tsai K.-S.; Yu M.-W.
臺大學術典藏	2022-01-24T09:31:52Z	Host genetic variants and hepatitis b virologic features in HBeAg-negative hepatitis B carriers with long-term biochemical remission	Lin C.-L.; Tseng T.-C.; Su T.-H.; CHUN-JEN LIU; Chen P.-J.; Lai M.-Y.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2022-01-24T09:31:51Z	Interleukin 28B genetic polymorphisms play a minor role in identifying optimal treatment duration in HCV genotype 1 slow responders to pegylated interferon plus ribavirin	Liu C.-H.; Liang C.-C.; CHUN-JEN LIU; Tseng T.-C.; Lin C.-L.; Yang S.-S.; Su T.-H.; Lin J.-W.; Chen J.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2022-01-24T09:31:51Z	Interleukin 28B genetic polymorphisms and viral factors help identify HCV genotype-1 patients who benefit from 24-week pegylated interferon plus ribavirin therapy	Liu C.-H.; Liang C.-C.; CHUN-JEN LIU; Tseng T.-C.; Lin C.-L.; Yang S.-S.; Su T.-H.; Hsu S.-J.; Lin J.-W.; Chen J.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2022-01-24T09:31:49Z	Influences of tobacco and alcohol use on hepatocellular carcinoma survival	Shih W.-L.; Chang H.-C.; Liaw Y.-F.; Lin S.-M.; Lee S.-D.; Chen P.-J.; CHUN-JEN LIU; Lin C.-L.; Yu M.-W.
臺大學術典藏	2022-01-24T09:31:47Z	Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-up	Yu M.-L.; Lee C.-M.; Chen C.-L.; Chuang W.-L.; Lu S.-N.; Liu C.-H.; Wu S.-S.; Liao L.-Y.; Kuo H.-T.; Chao Y.-C.; Tung S.-Y.; Yang S.-S.; Kao J.-H.; Su W.-W.; Lin C.-L.; Yang H.-C.; Chen P.-J.; Chen D.-S.; CHUN-JEN LIU
臺大學術典藏	2022-01-24T09:31:45Z	Impact of Genetic Heterogeneity in Polymerase of Hepatitis B Virus on Dynamics of Viral Load and Hepatitis B Progression	Huang C.-J.; Wu C.-F.; Lan C.-Y.; Sung F.-Y.; Lin C.-L.; CHUN-JEN LIU; Liu H.-F.; Yu M.-W.
臺大學術典藏	2022-01-24T09:31:44Z	Identification of a liver cirrhosis signature in plasma for predicting hepatocellular carcinoma risk in a population-based cohort of hepatitis B carriers	Liu C.-C.; Wang Y.-H.; Chuang E.Y.; Tsai M.-H.; Chuang Y.-H.; Lin C.-L.; CHUN-JEN LIU; Hsiao B.-Y.; Lin S.-M.; Liu L.-Y.; Yu M.-W.
臺大學術典藏	2022-01-24T09:31:38Z	Circulating programmed death-1 as a marker for sustained high hepatitis b viral load and risk of hepatocellular carcinoma e95870	Cheng H.-Y.; Kang P.-J.; Chuang Y.-H.; Wang Y.-H.; Jan M.-C.; Wu C.-F.; Lin C.-L.; CHUN-JEN LIU; Liaw Y.-F.; Lin S.-M.; Chen P.-J.; Lee S.-D.; Yu M.-W.
臺大學術典藏	2022-01-24T09:31:37Z	Serum biomarkers predictive of significant fibrosis and cirrhosis in chronic hepatitis B	Lin C.-L.; Liu C.-H.; Wang C.-C.; Liang C.-C.; Su T.-H.; CHUN-JEN LIU; Kao J.-H.
臺大學術典藏	2022-01-24T09:31:36Z	Comparison of abbott realtime HCV genotype II with versant line probe assay 2.0 for hepatitis C virus genotyping	Liu C.-H.; Liang C.-C.; CHUN-JEN LIU; Lin C.-L.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2022-01-24T09:31:35Z	Development of risk scoring system for stratifying population for hepatocellular carcinoma screening	Hung Y.-C.; Lin C.-L.; CHUN-JEN LIU; Hung H.; Lin S.-M.; Lee S.-D.; Chen P.-J.; Chuang S.-C.; Yu M.-W.
臺大學術典藏	2022-01-24T09:31:34Z	Peginterferon plus weight-based ribavirin for treatment-na?ve hepatitis C virus genotype 2 patients not achieving rapid virologic response: A randomized trial	Liu C.-H.; Huang C.-F.; CHUN-JEN LIU; Dai C.-Y.; Huang J.-F.; Lin J.-W.; Liang C.-C.; Yang S.-S.; Lin C.-L.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; Kao J.-H.; Yu M.-L.
臺大學術典藏	2022-01-24T09:31:32Z	Peginterferon alfa-2a plus Weight-Based or Flat-Dose Ribavirin for Treatment-Na?ve Hepatitis C Virus Genotype 2 Rapid Responders: A Randomized Trial	Liu C.-H.; Huang C.-F.; CHUN-JEN LIU; Dai C.-Y.; Huang J.-F.; Lin J.-W.; Liang C.-C.; Yang S.-S.; Lin C.-L.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; Kao J.-H.; Yu M.-L.
臺大學術典藏	2022-01-24T09:31:28Z	Progressive accumulation of mutations in the hepatitis B virus genome and its impact on time to diagnosis of hepatocellular carcinoma	Sung F.-Y.; Lan C.-Y.; Huang C.-J.; Lin C.-L.; CHUN-JEN LIU; Chen P.; Lin S.-M.; Yu M.-W.
臺大學術典藏	2022-01-24T09:31:25Z	Genome-wide identification of blood DNA methylation patterns associated with early-onset hepatocellular carcinoma development in hepatitis B carriers	Kao W.-Y.; Yang S.-H.; Liu W.-J.; Yeh M.-Y.; Lin C.-L.; CHUN-JEN LIU; Huang C.-J.; Lin S.-M.; Lee S.-D.; Chen P.-J.; Yu M.-W.
臺大學術典藏	2022-01-24T09:31:24Z	Influence of Metabolic Risk Factors on Risk of Hepatocellular Carcinoma and Liver-Related Death in Men With Chronic Hepatitis B: A Large Cohort Study	Yu M.-W.; Lin C.-L.; CHUN-JEN LIU; Yang S.-H.; Tseng Y.-L.; Wu C.-F.
臺大學術典藏	2022-01-24T09:31:15Z	Smoking and Hepatitis B Virus–Related Hepatocellular Carcinoma Risk: The Mediating Roles of Viral Load and Alanine Aminotransferase	Wang Y.-H.; Chuang Y.-H.; Wu C.-F.; Jan M.-C.; Wu W.-J.; Lin C.-L.; CHUN-JEN LIU; Yang Y.-C.; Chen P.-J.; Lin S.-M.; Tsai M.-H.; Huang Y.-W.; Yu M.-W.
臺大學術典藏	2022-01-24T09:31:13Z	Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East Asian non-cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysis	Liu C.-H.; Shih Y.-L.; Yang S.-S.; Lin C.-L.; Fang Y.-J.; Cheng P.-N.; Chen C.-Y.; Peng C.-Y.; Hsieh T.-Y.; Chiu Y.-C.; Su T.-H.; CHUN-JEN LIU; Yang H.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2022-01-24T09:31:03Z	Longitudinal change of metabolite profile and its relation to multiple risk factors for the risk of developing hepatitis B-related hepatocellular carcinoma	Huang B.-Y.; Tsai M.-R.; Hsu J.-K.; Lin C.-Y.; Lin C.-L.; Hu J.-T.; Huang Y.-W.; CHUN-JEN LIU; Wu W.-J.; Wu C.-F.; Sung F.-Y.; Chen P.-J.; Liang H.-J.; Lin S.-M.; Yu M.-W.

顯示項目 111-135 / 848 (共34頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目

	English \| 正體中文 \| 简体中文 \| 總筆數 :0
	造訪人次 : 52293905 線上人數 : 658 教育部委託研究計畫計畫執行:國立臺灣大學圖書館